Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2024 Earnings Call Transcript

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2024 Earnings Call Transcript July 31, 2024

Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $2.42 EPS, expectations were $4.68.

Operator: Thank you for standing by. My name is Mandeep, and I’ll be your operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals 2024 Second Quarter Earnings Call. All lines have been placed on mute to prevent any background. After the speakers’ remarks there...